• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淀粉样 PET 的半定量和分级:欧洲阿尔茨海默病联合会(EADC)的一个项目。

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).

机构信息

Istituto Nazionale di Fisica Nucleare (INFN), Genova, via Dodecaneso 33, I-16146, Italy.

Istituto Nazionale di Fisica Nucleare (INFN), Genova, via Dodecaneso 33, I-16146, Italy; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.

出版信息

Neuroimage Clin. 2019;23:101846. doi: 10.1016/j.nicl.2019.101846. Epub 2019 May 4.

DOI:10.1016/j.nicl.2019.101846
PMID:31077984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6514268/
Abstract

BACKGROUND

amyloid-PET reading has been classically implemented as a binary assessment, although the clinical experience has shown that the number of borderline cases is non negligible not only in epidemiological studies of asymptomatic subjects but also in naturalistic groups of symptomatic patients attending memory clinics. In this work we develop a model to compare and integrate visual reading with two independent semi-quantification methods in order to obtain a tracer-independent multi-parametric evaluation.

METHODS

We retrospectively enrolled three cohorts of cognitively impaired patients submitted to F-florbetaben (53 subjects), F-flutemetamol (62 subjects), F-florbetapir (60 subjects) PET/CT respectively, in 6 European centres belonging to the EADC. The 175 scans were visually classified as positive/negative following approved criteria and further classified with a 5-step grading as negative, mild negative, borderline, mild positive, positive by 5 independent readers, blind to clinical data. Scan quality was also visually assessed and recorded. Semi-quantification was based on two quantifiers: the standardized uptake value (SUVr) and the ELBA method. We used a sigmoid model to relate the grading with the quantifiers. We measured the readers accord and inconsistencies in the visual assessment as well as the relationship between discrepancies on the grading and semi-quantifications.

CONCLUSION

It is possible to construct a map between different tracers and different quantification methods without resorting to ad-hoc acquired cases. We used a 5-level visual scale which, together with a mathematical model, delivered cut-offs and transition regions on tracers that are (largely) independent from the population. All fluorinated tracers appeared to have the same contrast and discrimination ability with respect to the negative-to-positive grading. We validated the integration of both visual reading and different quantifiers in a more robust framework thus bridging the gap between a binary and a user-independent continuous scale.

摘要

背景

淀粉样蛋白-PET 阅读经典地实施为二进制评估,尽管临床经验表明,不仅在无症状受试者的流行病学研究中,而且在就诊于记忆诊所的有症状患者的自然群体中,边界病例的数量都不少。在这项工作中,我们开发了一种模型,以比较和整合视觉阅读与两种独立的半定量方法,以便获得与示踪剂无关的多参数评估。

方法

我们回顾性地招募了三个认知障碍患者队列,他们分别接受了 F-氟比他滨(53 例)、F-氟甲基美金刚(62 例)和 F-氟比他滨(60 例) PET/CT,这三个队列分别来自于欧洲认知障碍疾病联盟(EADC)的 6 个欧洲中心。175 次扫描根据批准的标准进行了阳性/阴性的视觉分类,并由 5 位独立读者进行了 5 级评分(阴性、轻度阴性、边界、轻度阳性、阳性),读者对临床数据不知情。还对扫描质量进行了视觉评估和记录。半定量基于两种定量方法:标准化摄取值(SUVr)和 ELBA 方法。我们使用了一个 sigmoid 模型来将分级与定量相关联。我们测量了读者在视觉评估中的一致性和不一致性,以及分级和半定量之间的差异。

结论

在不依赖于专门获得的病例的情况下,有可能在不同的示踪剂和不同的定量方法之间构建一个图谱。我们使用了一个 5 级的视觉量表,它与一个数学模型一起,在很大程度上独立于人群,为示踪剂提供了分级的截止值和过渡区域。所有氟代示踪剂在阴性到阳性分级方面似乎都具有相同的对比度和区分能力。我们在更稳健的框架中验证了视觉阅读和不同定量方法的整合,从而弥合了二进制和用户独立连续尺度之间的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/8e02b4b5676b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/84676f290d87/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/b968ce670efd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/efa0cde517d0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/7f90d746a5fc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/f12cdaff2d14/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/8e02b4b5676b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/84676f290d87/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/b968ce670efd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/efa0cde517d0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/7f90d746a5fc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/f12cdaff2d14/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3a/6514268/8e02b4b5676b/gr6.jpg

相似文献

1
Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).淀粉样 PET 的半定量和分级:欧洲阿尔茨海默病联合会(EADC)的一个项目。
Neuroimage Clin. 2019;23:101846. doi: 10.1016/j.nicl.2019.101846. Epub 2019 May 4.
2
Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.对18F-氟代甲基多巴PET活性进行自动定量,以将扫描结果分类为脑淀粉样蛋白阴性或阳性:与视觉图像读取结果的一致性。
J Nucl Med. 2014 Oct;55(10):1623-8. doi: 10.2967/jnumed.114.142109. Epub 2014 Aug 21.
3
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.[11C]匹兹堡化合物B(PiB)与[18F]氟代甲磺酸去甲替林在正常对照者和阿尔茨海默病患者中的定性和定量成像特征比较。
Neuroimage Clin. 2015 Oct 14;9:592-8. doi: 10.1016/j.nicl.2015.10.007. eCollection 2015.
4
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?比较淀粉样蛋白-PET 阅读的视觉标准:标准合并能否降低评分者间的变异性?
Q J Nucl Med Mol Imaging. 2020 Dec;64(4):414-421. doi: 10.23736/S1824-4785.19.03124-8. Epub 2019 May 8.
5
Toward a Universal Readout for F-Labeled Amyloid Tracers: The CAPTAINs Study.朝向 F 标记淀粉样蛋白示踪剂的通用读出:CAPTAINs 研究。
J Nucl Med. 2021 Jul 1;62(7):999-1005. doi: 10.2967/jnumed.120.250290. Epub 2021 Mar 12.
6
Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification.低剂量 CT 用于 PET 图像的空间标准化:用于淀粉样蛋白-PET 半定量的验证程序。
Neuroimage Clin. 2018 Jul 19;20:153-160. doi: 10.1016/j.nicl.2018.07.013. eCollection 2018.
7
Optimized classification of F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.使用标准化摄取值(SUVR)定量方法对F-氟贝他班PET扫描结果进行阳性和阴性的优化分类,并与视觉评估进行比较。
Neuroimage Clin. 2017 May 13;15:325-332. doi: 10.1016/j.nicl.2017.04.025. eCollection 2017.
8
Parametric imaging of dual-time window [F]flutemetamol and [F]florbetaben studies.双时窗 [F]氟替美莫和 [F]氟比洛芬的参数成像研究。
Neuroimage. 2021 Jul 1;234:117953. doi: 10.1016/j.neuroimage.2021.117953. Epub 2021 Mar 21.
9
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.注射氟曲美他酚 F18 后β-淀粉样蛋白 PET 成像的死后组织病理学基础。
Acta Neuropathol Commun. 2016 Dec 12;4(1):130. doi: 10.1186/s40478-016-0399-z.
10
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.阿尔茨海默病患者和健康对照者用氟比苯(18F)行脑淀粉样蛋白 PET:一项多中心 2 期诊断研究。
Lancet Neurol. 2011 May;10(5):424-35. doi: 10.1016/S1474-4422(11)70077-1. Epub 2011 Apr 8.

引用本文的文献

1
Concordance Between Amyloid-PET Quantification and Real-World Visual Reads.淀粉样蛋白PET定量与实际视觉读数之间的一致性
JAMA Neurol. 2025 Jul 28. doi: 10.1001/jamaneurol.2025.2218.
2
Visual assessments of 11 C-Pittsburgh compound-B PET vs. 18 F-flutemetamol PET across the age spectrum.11C-Pittsburgh 化合物-B PET 与 18F-氟噻美PET 视觉评估在全年龄段的比较。
Nucl Med Commun. 2024 Dec 1;45(12):1047-1054. doi: 10.1097/MNM.0000000000001902. Epub 2024 Sep 13.
3
Novel β-amyloid PET Imaging Study of [F]92 in Patients with Cognitive Decline.

本文引用的文献

1
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?比较淀粉样蛋白-PET 阅读的视觉标准:标准合并能否降低评分者间的变异性?
Q J Nucl Med Mol Imaging. 2020 Dec;64(4):414-421. doi: 10.23736/S1824-4785.19.03124-8. Epub 2019 May 8.
2
Assessing Amyloid Pathology in Cognitively Normal Subjects Using F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods.使用 F-Flutemetamol PET 评估认知正常受试者的淀粉样蛋白病理学:比较视觉解读和定量方法。
J Nucl Med. 2019 Apr;60(4):541-547. doi: 10.2967/jnumed.118.211532. Epub 2018 Oct 12.
3
Amyloid involvement in subcortical regions predicts cognitive decline.
认知功能减退患者中新型β淀粉样蛋白[F]92正电子发射断层显像研究
ACS Omega. 2024 Aug 1;9(32):34675-34683. doi: 10.1021/acsomega.4c03412. eCollection 2024 Aug 13.
4
New horizons in the diagnosis and management of Alzheimer's Disease in older adults.老年人阿尔茨海默病诊断与管理的新视野。
Age Ageing. 2024 Feb 1;53(2). doi: 10.1093/ageing/afae005.
5
Feasibility evaluation of middle-phase F-florbetaben positron emission tomography imaging using centiloid quantification and visual assessment.使用百分位数定量和视觉评估对中期F-氟代苯并噻唑正电子发射断层扫描成像进行可行性评估。
Quant Imaging Med Surg. 2023 Aug 1;13(8):4806-4815. doi: 10.21037/qims-23-58. Epub 2023 Jun 14.
6
A multicenter evaluation of a deep learning software (LungQuant) for lung parenchyma characterization in COVID-19 pneumonia.多中心评估深度学习软件(LungQuant)在 COVID-19 肺炎肺实质特征中的应用。
Eur Radiol Exp. 2023 Apr 10;7(1):18. doi: 10.1186/s41747-023-00334-z.
7
A comparison of advanced semi-quantitative amyloid PET analysis methods.先进的半定量淀粉样 PET 分析方法比较。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4097-4108. doi: 10.1007/s00259-022-05846-1. Epub 2022 Jun 2.
8
Quantification of amyloid PET for future clinical use: a state-of-the-art review.用于未来临床应用的淀粉样 PET 的量化:最新综述。
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3508-3528. doi: 10.1007/s00259-022-05784-y. Epub 2022 Apr 7.
9
Evaluation of semi-quantitative measures of F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease.用于阿尔茨海默病临床诊断的F-氟代去甲肾上腺素PET半定量测量评估。
Quant Imaging Med Surg. 2022 Jan;12(1):493-509. doi: 10.21037/qims-21-188.
10
The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community.一种用于治疗阿尔茨海默病的疾病修饰疗法的获批:对核医学领域的影响及后果
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y.
淀粉样蛋白在皮质下区域的沉积可预测认知能力下降。
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2368-2376. doi: 10.1007/s00259-018-4081-5. Epub 2018 Jul 6.
4
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
5
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.阿尔茨海默病的脑脊液生物标志物与淀粉样蛋白-β PET 一致,并可预测临床进展:在 BioFINDER 和 ADNI 队列中使用全自动免疫分析的研究。
Alzheimers Dement. 2018 Nov;14(11):1470-1481. doi: 10.1016/j.jalz.2018.01.010. Epub 2018 Mar 1.
6
In vivo staging of regional amyloid deposition.区域淀粉样蛋白沉积的体内分期
Neurology. 2017 Nov 14;89(20):2031-2038. doi: 10.1212/WNL.0000000000004643. Epub 2017 Oct 18.
7
A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain.阿尔茨海默病的系统观——超越大脑的β淀粉样蛋白代谢见解
Nat Rev Neurol. 2017 Nov;13(11):703. doi: 10.1038/nrneurol.2017.147. Epub 2017 Oct 13.
8
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.脑脊液Aβ1-42/Aβ1-40比值可提高在临床环境中与淀粉样蛋白PET诊断阿尔茨海默病的一致性。
J Alzheimers Dis. 2017;60(2):561-576. doi: 10.3233/JAD-170327.
9
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.基于生物标志物的阿尔茨海默病早期诊断的战略路线图。
Lancet Neurol. 2017 Aug;16(8):661-676. doi: 10.1016/S1474-4422(17)30159-X. Epub 2017 Jul 11.
10
Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship.中老年人群纵向认知衰退与淀粉样蛋白负荷的关联:剂量反应关系的证据
JAMA Neurol. 2017 Jul 1;74(7):830-838. doi: 10.1001/jamaneurol.2017.0892.